[SYRE] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Jun-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -19.42%
YoY- -280.52%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 0 0 2,378 1,479 1,373 3,427 0 -
PBT -21,418 -18,019 -9,414 -6,632 -5,430 -1,427 -2,396 44.01%
Tax 0 0 0 0 0 0 0 -
NP -21,418 -18,019 -9,414 -6,632 -5,430 -1,427 -2,396 44.01%
Tax Rate - - - - - - - -
Total Cost 21,418 18,019 11,792 8,111 6,803 4,854 2,396 44.01%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 0.00 0.00 -395.88 -448.41 -395.48 -41.64 0.00 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -10.11 -13.72 -11.43 -11.75 -11.53 -5.23 0.00 -
EPS Diluted -10.11 -13.72 -11.43 -11.75 -11.53 -5.23 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.